Abstract
The development and applications of molecular imprinting-based chemiluminescence detection method are reviewed with special attention to pharmaceutical analysis. This review is organized according to the fundamental types of chemiluminescence reactions involved. The marriage of this technique with immunoassay is also discussed.
Keywords: Chemiluminescence, Molecularly imprinted polymer, Sensor, Solid-phase extraction, Pharmaceutical, Review
Current Pharmaceutical Analysis
Title: Molecular Imprinting-Based Chemiluminescence Techniques in Pharmaceutical Analysis
Volume: 6 Issue: 1
Author(s): Jianxiu Du
Affiliation:
Keywords: Chemiluminescence, Molecularly imprinted polymer, Sensor, Solid-phase extraction, Pharmaceutical, Review
Abstract: The development and applications of molecular imprinting-based chemiluminescence detection method are reviewed with special attention to pharmaceutical analysis. This review is organized according to the fundamental types of chemiluminescence reactions involved. The marriage of this technique with immunoassay is also discussed.
Export Options
About this article
Cite this article as:
Du Jianxiu, Molecular Imprinting-Based Chemiluminescence Techniques in Pharmaceutical Analysis, Current Pharmaceutical Analysis 2010; 6 (1) . https://dx.doi.org/10.2174/157341210790780212
DOI https://dx.doi.org/10.2174/157341210790780212 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Biological Activities of Artemisinin Derivatives Beyond Malaria
Current Topics in Medicinal Chemistry TRP Channels and Cancer: New Targets for Diagnosis and Chemotherapy
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of Integrin-Mediated Cell Adhesion in Atherosclerosis: Pathophysiology and Clinical Opportunities
Current Pharmaceutical Design Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Cardiovascular Risk in Patients with Primary Hyperparathyroidism
Current Pharmaceutical Design Targeting the Immune System in Cancer
Current Pharmaceutical Biotechnology Radiolabeled Small Molecule Inhibitors of VEGFR - Recent Advances
Current Pharmaceutical Design Optimization of the Enzymolysis Conditions for Scorpion Peptides and Evaluation of its Antitumor Activity
Current Signal Transduction Therapy Advancement of Targeted Ultrasound Contrast Agents and their Applications in Molecular Imaging and Targeted Therapy
Current Pharmaceutical Design Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy
Current Drug Targets 3,6-dichloro-1,2,4,5-Tetrazine Assayed at High Doses in the Metastatic Breast Cancer Cell Line MDA-MB-231 Reduces Cell Numbers and Induces Apoptosis
Current Bioactive Compounds Bladder Cancer and Stem Cells
Current Signal Transduction Therapy A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer
Current Medicinal Chemistry Photo- and Sono-Dynamic Therapy: A Review of Mechanisms and Considerations for Pharmacological Agents Used in Therapy Incorporating Light and Sound
Current Pharmaceutical Design Role of Antioxidants, Essential Fatty Acids, Carnitine, Vitamins, Phytochemicals and Trace Elements in the Treatment of Diabetes Mellitus and its Chronic Complications
Endocrine, Metabolic & Immune Disorders - Drug Targets Smart Inulin-Based Polycationic Nanodevices for siRNA Delivery
Current Drug Delivery Surface Modification of Nanocarriers for Cancer Therapy
Current Nanoscience Foods for Health and to Treat Diseases
Current Pediatric Reviews Recent Advances in the Rationale Design of GPER Ligands
Current Medicinal Chemistry P-gp Inhibition-Based Strategies for Modulating Pharmacokinetics of Anticancer Drugs: An Update
Current Drug Metabolism